Medlive Technology Co., Ltd. (HK:2192)
:2192
Want to see HK:2192 full AI Analyst Report?
Total Valuation
Medlive Technology Co., Ltd. has a market cap or net worth of HK$5.94B. The enterprise value is HK$2.60B.
Market CapHK$5.94B
Enterprise ValueHK$2.60B
Share Statistics
Medlive Technology Co., Ltd. has 740,114,140 shares outstanding. The number of shares has decreased by -2.65% in one year.
Shares Outstanding740,114,140
Owned by Insiders―
Owned by Institutions―
Financial Efficiency
Medlive Technology Co., Ltd.’s return on equity (ROE) is 0.07 and return on invested capital (ROIC) is 1.79%.
Return on Equity (ROE)0.07
Return on Assets (ROA)0.06
Return on Invested Capital (ROIC)1.79%
Return on Capital Employed (ROCE)0.02
Revenue Per Employee859.65K
Profits Per Employee482.31K
Employee Count747
Asset Turnover0.12
Inventory Turnover0.00
Valuation Ratios
The current PE Ratio of Medlive Technology Co., Ltd. is 19.2. Medlive Technology Co., Ltd.’s PEG ratio is 2.75.
PE Ratio19.2
PS Ratio10.00
PB Ratio1.32
Price to Fair Value1.32
Price to FCF52.74
Price to Operating Cash Flow33.14
PEG Ratio2.75
Income Statement
In the last 12 months, Medlive Technology Co., Ltd. had revenue of 642.15M and earned 334.34M in profits. Earnings per share was 0.46.
Revenue642.15M
Gross Profit385.44M
Operating Income91.87M
Pretax Income360.29M
Net Income334.34M
EBITDA174.99M
Earnings Per Share (EPS)0.46
Cash Flow
In the last 12 months, operating cash flow was 154.08M and capital expenditures -11.64M, giving a free cash flow of 142.44M billion.
Operating Cash Flow154.08M
Free Cash Flow142.44M
Free Cash Flow per Share0.19
Dividends & Yields
Medlive Technology Co., Ltd. pays an annual dividend of HK$0.128, resulting in a dividend yield of 2.72%
Dividend Per ShareHK$0.128
Dividend Yield2.72%
Payout Ratio57.16%
Free Cash Flow Yield―
Earnings Yield―
Stock Price Statistics
Beta1.32
52-Week Price Change-34.73%
50-Day Moving Average8.43
200-Day Moving Average10.70
Relative Strength Index (RSI)39.82
Average Volume (3m)1.46M
Important Dates
Medlive Technology Co., Ltd. upcoming earnings date is Sep 1, 2026, TBA (Confirmed).
Last Earnings DateMar 26, 2026
Next Earnings DateSep 1, 2026
Ex-Dividend Date―
Financial Position
Medlive Technology Co., Ltd. as a current ratio of 19.09, with Debt / Equity ratio of 0.21%
Current Ratio19.09
Quick Ratio19.09
Debt to Market Cap<0.01
Net Debt to EBITDA-14.62
Interest Coverage Ratio166.44
Taxes
In the past 12 months, Medlive Technology Co., Ltd. has paid 12.40M in taxes.
Income Tax12.40M
Effective Tax Rate0.03
Enterprise Valuation
Medlive Technology Co., Ltd. EV to EBITDA ratio is 22.06, with an EV/FCF ratio of 31.72.
EV to Sales6.01
EV to EBITDA22.06
EV to Free Cash Flow31.72
EV to Operating Cash Flow28.70
Balance Sheet
Medlive Technology Co., Ltd. has HK$3.72B in cash and marketable securities with HK$10.11M in debt, giving a net cash position of HK$3.71B billion.
Cash & Marketable SecuritiesHK$3.72B
Total DebtHK$10.11M
Net CashHK$3.71B
Net Cash Per ShareHK$5.02
Tangible Book Value Per ShareHK$6.34
Margins
Gross margin is 60.02%, with operating margin of 14.31%, and net profit margin of 52.07%.
Gross Margin60.02%
Operating Margin14.31%
Pretax Margin56.11%
Net Profit Margin52.07%
EBITDA Margin27.25%
EBIT Margin26.06%
Analyst Forecast
The average price target for Medlive Technology Co., Ltd. is HK$13.10, which is 11.43% higher than the current price. The consensus rating is Strong Buy
Price TargetHK$13.10
Price Target Upside33.27% Upside
Analyst ConsensusStrong Buy
Analyst Count3
Revenue Growth Forecast15.04%
EPS Growth Forecast5.57%